Search
Searching Evidence for "Perilla" · search everything instead
Each record is a registered study, a systematic-review registration or a publication. A registered or ongoing study is not a finding, and animal or cell research does not show an effect in people. The same study can appear under more than one subject, so the number of records is not a count of independent studies. You can also search an exact DOI, PubMed ID, NCT or CRD number. How to read these records.
19 study records (showing up to 30 per record type)
-
Systematic review registration CRD42023413131 Registered protocol, no results here: Review OngoingEffect of dietary alpha-linolenic acid supplementation on inflammatory biomarkers in individuals with dyslipidemias: A systematic review and meta-analysis of randomized controlled trialsCondition or outcome area: Dyslipidemias.
-
Systematic review registration CRD42021255527 Registered protocol, no results here: Review Completed publishedPerillyl alcohol for cancer treatmentCondition or outcome area: Cancer treatment2021-06-18 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record
-
Systematic review registration CRD42018082207 Registered protocol, no results here: Review OngoingLimonene, perillyl alcohol, perillic acid and perillaldehyde as anticancer agents: a systematic reviewCondition or outcome area: Cancer treatment Cancer prevention2018-01-04 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record
-
Systematic review registration CRD42018082207 Registered protocol, no results here: Review OngoingLimonene, perillyl alcohol, perillic acid and perillaldehyde as anticancer agents: a systematic reviewCondition or outcome area: Cancer treatment Cancer prevention2018-01-04 · Subject: Perillic acid; 7694-45-3; (-)-perillic acid; Perillicacid; 4-Isopropenylcyclohex-1-enecarboxylic acid; 4-prop-1-en-2-ylcyclohexene-1-carboxylic acid; PKS69DU4ZQ; 4-(1-methylethenyl)-1-cyclohexene-1-carboxylic acid; 1-Cyclohexene-1-carboxylicacid, 4-(1-methylethenyl)-; CHEBI:36999 · open the ingredient record
-
Systematic review registration CRD42018082207 Registered protocol, no results here: Review OngoingLimonene, perillyl alcohol, perillic acid and perillaldehyde as anticancer agents: a systematic reviewCondition or outcome area: Cancer treatment Cancer prevention2018-01-04 · Subject: Perillaldehyde; Perillyl aldehyde; 2111-75-3; Perilla aldehyde; Perillal; Perillic aldehyde; P-Mentha-1,8-dien-7-al; Dihydrocuminyl aldehyde; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-; 4-prop-1-en-2-ylcyclohexene-1-carbaldehyde · open the ingredient record
-
Systematic review registration CRD42018082207 Registered protocol, no results here: Review OngoingLimonene, perillyl alcohol, perillic acid and perillaldehyde as anticancer agents: a systematic reviewCondition or outcome area: Cancer treatment Cancer prevention2018-01-04 · Subject: L-limonen; Limonene, (-)-; (-)-Limonene; 5989-54-8; l-Limonene; (S)-(-)-Limonene; (S)-Limonene; (S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene; beta-Limonene; (-)-(4S)-Limonene · open the ingredient record
-
Publication PMID 36070663 Research model: Animal ExperimentPerillyl alcohol attenuates chronic restraint stress aggravated dextran sulfate sodium-induced ulcerative colitis by modulating TLR4/NF-κB and JAK2/STAT3 signaling pathwaysCondition or outcome area: chronic inflammatory immune bowel disease; ulcerative colitis; Ulcerative colitis; chronic inflammation; decreased ulcerationsPhytomedicine · 2022 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record · DOI 10.1016/j.phymed.2022.154415
-
Publication PMID 35030388 Research model: Animal & Cell ExperimentPerillyl alcohol attenuates rheumatoid arthritis via regulating TLR4/NF-κB and Keap1/Nrf2 signaling pathways: A comprehensive study onin-vitro and in-vivo experimental modelsCondition or outcome area: joint inflammation; arthritis; Rheumatoid arthritis; bone erosion; rheumatoid arthritis; chronic and idiopathic autoimmune disorder; pannusPhytomedicine · 2022 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record · DOI 10.1016/j.phymed.2022.153926
-
Publication PMID 34929480 Research model: Animal & Cell ExperimentPerillyl alcohol inhibits keratinocyte proliferation and attenuates imiquimod-induced psoriasis like skin-inflammation by modulating NF-κB and STAT3 signaling pathwaysCondition or outcome area: psoriatic like skin inflammation; chronic inflammatory and proliferative skin disease; epidermal hyperplasia; splenomegaly; imiquimod; skin lesions; psoriasis; acanthosis; psoriasis-like skin inflammation; Psoriasis; hyper-keratosisInt Immunopharmacol · 2021 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record · DOI 10.1016/j.intimp.2021.108436
-
Publication PMID 33649109 Research model: Animal ExperimentPerillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malariaCondition or outcome area: vascular dysfunction; Cerebral malaria; cerebrovascular dysfunction; inflammatory infiltrates; immunovasculopathy; cerebral oedema; Cerebral MalariaAntimicrob Agents Chemother · 2021 · Subject: Perillyl alcohol; 536-59-4; Perilla alcohol; Perillol; Isocarveol; p-Mentha-1,8-dien-7-ol; Hydrocumin alcohol; 1-Cyclohexene-1-methanol, 4-(1-methylethenyl)-; Dihydrocuminyl alcohol; Iso-carveol · open the ingredient record · DOI 10.1128/AAC.00004-21
-
Publication PMID 35204061 Research model: Animal & Cell ExperimentTherapeutic Potential of Perillaldehyde in Ameliorating Vulvovaginal Candidiasis by Reducing Vaginal Oxidative Stress and ApoptosisCondition or outcome area: Vulvovaginal candidiasis; Candida albicansAntioxidants (Basel) · 2022 · Subject: Perillaldehyde; Perillyl aldehyde; 2111-75-3; Perilla aldehyde; Perillal; Perillic aldehyde; P-Mentha-1,8-dien-7-al; Dihydrocuminyl aldehyde; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-; 4-prop-1-en-2-ylcyclohexene-1-carbaldehyde · open the ingredient record · DOI 10.3390/antiox11020178
-
Publication PMID 34903262 Research model: Animal & Cell ExperimentPerillaldehyde improves cognitive function in vivo and in vitro by inhibiting neuronal damage via blocking TRPM2/NMDAR pathwayCondition or outcome area: vascular dementia; cognitive dysfunction syndrome; cerebrovascular diseases; epilepsy; insomnia; Vascular cognitive dysfunction; central nervous system diseasesChin Med · 2021 · Subject: Perillaldehyde; Perillyl aldehyde; 2111-75-3; Perilla aldehyde; Perillal; Perillic aldehyde; P-Mentha-1,8-dien-7-al; Dihydrocuminyl aldehyde; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-; 4-prop-1-en-2-ylcyclohexene-1-carbaldehyde · open the ingredient record · DOI 10.1186/s13020-021-00545-9
-
Publication PMID 34738877 Research model: Cell ExperimentPerillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-κB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell linesCondition or outcome area: prostate cancer; PCa; cancerBioengineered · 2021 · Subject: Perillaldehyde; Perillyl aldehyde; 2111-75-3; Perilla aldehyde; Perillal; Perillic aldehyde; P-Mentha-1,8-dien-7-al; Dihydrocuminyl aldehyde; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-; 4-prop-1-en-2-ylcyclohexene-1-carbaldehyde · open the ingredient record · DOI 10.1080/21655979.2021.2001237
-
Publication PMID 32822688 Research model: Animal & Cell ExperimentPerillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasisCondition or outcome area: oropharyngeal candidiasisBiochem Pharmacol · 2020 · Subject: Perillaldehyde; Perillyl aldehyde; 2111-75-3; Perilla aldehyde; Perillal; Perillic aldehyde; P-Mentha-1,8-dien-7-al; Dihydrocuminyl aldehyde; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethenyl)-; 4-prop-1-en-2-ylcyclohexene-1-carbaldehyde · open the ingredient record · DOI 10.1016/j.bcp.2020.114201
-
Publication PMID 35058774 Research model: Animal ExperimentPerilla Leaf Extract (PLE) Attenuates COPD Airway Inflammation via the TLR4/Syk/PKC/NF-κB Pathway In Vivo and In VitroCondition or outcome area: COPD inflammation; Chronic obstructive pulmonary disease; airway inflammation; tumor; respiratory disease; COPD airway inflammationFront Pharmacol · 2022 · Subject: Zi Su Ye; 紫苏叶; Perilla Leaf; Folium Perillae; Perillae Folium · open the herb record · DOI 10.3389/fphar.2021.763624
-
Publication PMID 36420586 Research model: Cell ExperimentPerilla frutescens L. alleviates trimethylamine N-oxide-induced apoptosis in the renal tubule by regulating ASK1-JNK phosphorylationCondition or outcome area: kidney injury; chronic kidney disease; renal injuryPhytother Res · 2022 · Subject: Zi Su; 紫苏; Perilla Frutescens · open the herb record · DOI 10.1002/ptr.7684
-
Publication PMID 34899287 Research model: Cell ExperimentExploring the Critical Components and Therapeutic Mechanisms of Perilla frutescens L. in the Treatment of Chronic Kidney Disease via Network PharmacologyCondition or outcome area: Chronic kidney disease; chronic progressive disease; chronic renal failure; multi-system damageFront Pharmacol · 2021 · Subject: Zi Su; 紫苏; Perilla Frutescens · open the herb record · DOI 10.3389/fphar.2021.717744
-
Publication PMID 33921322 Research model: Cell ExperimentPerilla frutescens Extracts Enhance DNA Repair Response in UVB Damaged HaCaT CellsNutrients · 2021 · Subject: Zi Su; 紫苏; Perilla Frutescens · open the herb record · DOI 10.3390/nu13041263
-
Publication PMID 31743741 Research model: Animal ExperimentPerilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy miceCondition or outcome area: diabetic; type-2 diabetic KKAy; type 2 diabetes mellitusFood Chem Toxicol · 2020 · Subject: Zi Su; 紫苏; Perilla Frutescens · open the herb record · DOI 10.1016/j.fct.2019.110965